-
2861“…BACKGROUND: Oral microbiota reported to be associated with pancreatic diseases, including pancreatic cancer. However, the association of oral microbiome and pancreatic cancer has not been reviewed systematically. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2862
-
2863por Nimmakayala, Rama Krishna, Ogunleye, Ayoola O., Parte, Seema, Krishna Kumar, Nivedeta, Raut, Pratima, Varadharaj, Venkatesh, Perumal, Naveen Kumar, Nallasamy, Palanisamy, Rauth, Sanchita, Cox, Jesse L., Lele, Subodh M., Batra, Surinder K., Ponnusamy, Moorthy P.“…This study identified a regulatory axis of PDAC initiation and its targeting, paving the way for developing targeted therapeutic strategies for pancreatic cancer patients.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2864por Deborde, Sylvie, Gusain, Laxmi, Powers, Ann, Marcadis, Andrea, Yu, Yasong, Chen, Chun-Hao, Frants, Anna, Kao, Elizabeth, Tang, Laura H., Vakiani, Efsevia, Amisaki, Masataka, Balachandran, Vinod P., Calo, Annalisa, Omelchenko, Tatiana, Jessen, Kristjan R., Reva, Boris, Wong, Richard J.“…SIGNIFICANCE: How the tumor microenvironment participates in pancreatic cancer progression is not fully understood. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2865
-
2866por Tian, Guo, Xu, Danxia, He, Yinghua, Chai, Weilu, Deng, Zhuang, Cheng, Chao, Jin, Xinyan, Wei, Guyue, Zhao, Qiyu, Jiang, Tianan“…This study aimed to real-timely differentiate a pancreatic cancer (PC) or a non-pancreatic cancer (NPC) lesion via endoscopic ultrasonography (EUS) image. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2867por Satake, Tomoyuki, Morizane, Chigusa, Rikitake, Ryoko, Higashi, Takahiro, Okusaka, Takuji, Kawai, AkiraEnlace del recurso
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2868por Sabanovic, Berina, Giulietti, Matteo, Cecati, Monia, Spolverato, Gaya, Benna, Clara, Pucciarelli, Salvatore, Piva, FrancescoEnlace del recurso
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2869“…Pancreatic cancer remains one of the deadliest forms of cancer with a 5-year survival rate of only 11%. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2870“…Despite the advances in the treatment of pancreatic cancer in the past decade, the prognosis for patients with pancreatic cancer remains poor. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2871por Shin, Sauyeun, Solorzano, Jacobo, Liauzun, Mehdi, Pyronnet, Stéphane, Bousquet, Corinne, Martineau, Yvan“…Despite the numerous translational alterations reported in pancreatic cancer, their consequences are greatly underestimated. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2872por Micalizzi, Douglas S., Che, Dante, Nicholson, Benjamin T., Edd, Jon F., Desai, Niyati, Lang, Evan R., Toner, Mehmet, Maheswaran, Shyamala, Ting, David T., Haber, Daniel A.“…Here, we show that an antibody (23C6) against cadherin proteins effectively suppresses blood-borne metastasis in mouse isogenic and xenograft models of triple negative breast and pancreatic cancers. The 23C6 antibody is remarkable in that it recognizes both the epithelial E-cadherin (CDH1) and mesenchymal OB-cadherin (CDH11), thus overcoming considerable heterogeneity across tumor cells. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2873por Zhao, Jie-Feng, Zou, Fei-Long, Zhu, Jin-Feng, Huang, Chao, Bu, Fan-Qin, Zhu, Zheng-Ming, Yuan, Rong-Fa“…Background: Nano drug delivery system (NDDS) can significantly improve the delivery and efficacy of drugs against pancreatic cancer (PC) in many ways. The purpose of this study is to explore the related research fields of NDDS for PC from the perspective of bibliometrics. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2874“…BACKGROUND & AIMS: Liver cancer (LC) and pancreatic cancer (PC) are often diagnosed at an advanced stage resulting in high mortality. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2875por Ramezankhani, Roya, Ghavidel, Afshin Abdi, Rashidi, Saadyeh, Rojhannezhad, Mahbubeh, Abolkheir, Hamid Reza, Mirhosseini, Malihe, Taleahmad, Sara, Vosough, Massoud“…Pancreatic cancer (PC) is one of the leading causes of cancer mortality worldwide, and its incidence and mortality rate in several regions is higher in male patients. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2876“…BACKGROUND: Pancreatic cancer does not show any symptoms in the early period and metastatic process is already passed when the diagnosis is done. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2877por Parisotto, Maxime, Vuong-Robillard, Nhung, Kalegari, Paloma, Meharwade, Thulaj, Joumier, Loick, Igelmann, Sebastian, Bourdeau, Véronique, Rowell, Marie-Camille, Pollak, Michael, Malleshaiah, Mohan, Schmitzer, Andréea, Ferbeyre, Gerardo“…Metformin use has been associated with reduced pancreatic cancer incidence and better survival in diabetics. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2878“…In this mini-review, we focus on the role of GSK-3β in pancreatic cancer. We demonstrate that the proposed anti-cancer roles of GSK-3β are not relevant to pancreatic cancer, and we argue why GSK-3β is, indeed, a very promising therapeutic target in pancreatic cancer.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2879“…Pancreatic cancer (PC) ranks as the seventh leading cause of cancer-associated mortality, and is predicted to become the third leading cause of cancer-associated mortality by the year 2025. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2880por Wang, James, Fite, Brett Z., Kare, Aris J., Wu, Bo, Raie, Marina, Tumbale, Spencer K., Zhang, Nisi, Davis, Ryan R., Tepper, Clifford G., Aviran, Sharon, Newman, Aaron M., King, Daniel A., Ferrara, Katherine W.“…Method: We designed and evaluated treatment strategies for breast and pancreatic cancer combining magnetic resonance-guided focused ultrasound (MRgFUS) ablation and antibody therapies. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto